NASDAQ:CME - CME Group Stock Price, Forecast & News

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group announced a dividend on Wednesday, December 11th. Shareholders of record on Friday, December 27th will be given a dividend of $2.50 per share on Wednesday, January 15th. The ex-dividend date of this dividend is Thursday, December 26th. This is a boost from CME Group's previous dividend of $1.75. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) issued its quarterly earnings results on Wednesday, October, 30th. The financial services provider reported $1.90 EPS for the quarter, beating the Zacks' consensus estimate of $1.75 by $0.15. The financial services provider had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a return on equity of 9.54% and a net margin of 40.93%. The firm's revenue was up 41.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 earnings per share. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for CME Group.

CME Group will be holding an earnings conference call on Wednesday, February 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

12 analysts have issued 12-month price targets for CME Group's shares. Their forecasts range from $173.00 to $252.00. On average, they anticipate CME Group's stock price to reach $213.40 in the next twelve months. This suggests a possible upside of 3.2% from the stock's current price. View Analyst Price Targets for CME Group.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CME Group.

News stories about CME stock have been trending negative this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CME Group earned a coverage optimism score of -2.5 on InfoTrie's scale. They also gave news stories about the financial services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for CME Group.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), Moody's (MCO), Msci (MSCI), Nasdaq (NDAQ), MarketAxess (MKTX), Cboe Global Markets (CBOE), Marlin Business Services (MRLN), California First National Bancorp (CFNB), Gain Capital (GCAP) and Interactive Brokers Group (IBKR).

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Walt Disney (DIS), Paypal (PYPL), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Mastercard (MA), Cisco Systems (CSCO) and Bank of America (BAC).

CME Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Manning & Napier Group LLC (0.10%), Nisa Investment Advisors LLC (0.03%), Windward Capital Management Co. CA (0.03%), State of Alaska Department of Revenue (0.03%), Peregrine Capital Management LLC (0.02%) and Commerzbank Aktiengesellschaft FI (0.02%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Manning & Napier Group LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Commerzbank Aktiengesellschaft FI, United Services Automobile Association, Assenagon Asset Management S.A., Gateway Investment Advisers LLC and First National Bank of Omaha. Company insiders that have sold CME Group company stock in the last year include Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was bought by a variety of institutional investors in the last quarter, including Selz Capital LLC, Viking Fund Management LLC, Nisa Investment Advisors LLC, DNB Asset Management AS, City Holding Co., Windward Capital Management Co. CA, Allworth Financial LP and Gradient Investments LLC. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $206.86.

CME Group has a market capitalization of $74.13 billion and generates $4.31 billion in revenue each year. The financial services provider earns $1.96 billion in net income (profit) each year or $6.82 on an earnings per share basis. CME Group employs 4,590 workers across the globe.View Additional Information About CME Group.

The official website for CME Group is http://www.cmegroup.com/.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]